Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden.
about
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational studyGlucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling.The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose MonitoringAvoiding or coping with severe hypoglycemia in patients with type 2 diabetes.Recent trends in life expectancy for people with type 1 diabetes in Sweden.Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in SwedenDEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetesCost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting
P2860
Q31099230-8AB2F7B3-F630-485B-B28E-CA549F46D9C2Q33879458-35BE9BE7-1D77-4CD4-B775-98451E7E2007Q35765550-703E012B-4695-465E-B44F-A9182188B4B2Q36267548-44CC083D-F5CF-4D38-98A2-F8A04459C4F2Q37054685-63586127-2798-48D5-8E23-1FF2DF06E248Q38318796-F1A7A966-8FFB-46D6-B492-3FC2415F156BQ40818308-064ACE68-F38D-4F06-AC6E-035931ED4D0AQ42371739-0723E35C-1C52-4B9A-84FA-6CAF204F6C32Q50076057-96909F3F-CC39-45F3-A71F-A8734C7C0B90Q51272007-4A81FF66-F43D-4E89-8A92-DFD7E2DF6AECQ57939193-34556E57-D187-4C41-B0CF-DCF8ADAE1F2AQ58788707-8F1C7118-9A24-4446-A481-25696E9FB6CE
P2860
Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@en
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@nl
type
label
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@en
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@nl
prefLabel
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@en
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@nl
P2093
P50
P356
P1433
P1476
Severe hypoglycemia and mortal ...... 1 diabetic patients in Sweden.
@en
P2093
Andrew J Palmer
Ann-Marie Svensson
William H Herman
P304
P356
10.2337/DC14-0405
P407
P577
2014-08-04T00:00:00Z